Copyright
        ©The Author(s) 2025.
    
    
        World J Psychiatry. Jul 19, 2025; 15(7): 106733
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.106733
Published online Jul 19, 2025. doi: 10.5498/wjp.v15.i7.106733
            Table 1 Comparison of clinical data between group a and group B, n (%)
        
    | Clinical data | Group A (n = 77) | Group B (n = 86) | t/χ2 | P value | 
| Gender (male) | 42 (54.55) | 45 (52.33) | 0.080 | 0.776 | 
| Age (years) | 53.74 ± 11.79 | 54.32 ± 10.85 | 0.327 | 0.744 | 
| BMI (kg/m²) | 23.18 ± 3.73 | 22.76 ± 3.95 | 0.695 | 0.487 | 
| Smoking status | 28 (36.36) | 34 (39.53) | 0.173 | 0.677 | 
| Alcohol consumption | 12 (15.58) | 11 (12.79) | 0.261 | 0.609 | 
| Duration of hypertension (years) | 4.92 ± 1.43 | 5.17 ± 1.79 | 0.977 | 0.329 | 
| SBP (mmHg) | 152.39 ± 7.87 | 153.48 ± 8.12 | 0.868 | 0.386 | 
| DBP (mmHg) | 94.19 ± 9.93 | 94.35 ± 10.21 | 0.101 | 0.919 | 
| TC (mmol/L) | 4.73 ± 1.15 | 4.62 ± 1.28 | 0.574 | 0.566 | 
| TG (mmol/L) | 1.33 ± 0.72 | 1.39 ± 0.82 | 0.493 | 0.622 | 
| LDL-C (mmol/L) | 2.78 ± 0.74 | 2.85 ± 0.72 | 0.611 | 0.541 | 
| HDL-C (mmol/L) | 1.41 ± 0.73 | 1.32 ± 0.77 | 0.763 | 0.446 | 
| FBG (mmol/L) | 4.97 ± 0.38 | 5.09 ± 0.52 | 1.665 | 0.097 | 
| BUN (mmol/L) | 5.12 ± 1.33 | 4.94 ± 1.45 | 0.822 | 0.411 | 
| Cr (μmol/L) | 69.74 ± 11.45 | 70.37 ± 12.16 | 0.339 | 0.734 | 
| UA (μmol/L) | 311.78 ± 76.95 | 316.43 ± 80.52 | 0.375 | 0.707 | 
| Use of amlodipine | 6 (7.79) | 5 (5.81) | 0.252 | 0.615 | 
            Table 2 Variable assignment
        
    | Independent variable | Assignment method | 
| ET-1 | Original value | 
| IL-6 | Original value | 
| SCF | Original value | 
| c-kit | Original value | 
            Table 3 Multivariate logistic regression analysis of factors influencing hypertension with depression
        
    | Factor | β | SE | Wald χ2 | P value | OR | 95%CI | 
| ET-1 | 1.086 | 0.372 | 8.674 | < 0.001 | 2.893 | 1.281-6.519 | 
| IL-6 | 1.148 | 0.411 | 7.657 | < 0.001 | 1.775 | 1.216-4.158 | 
| SCF | -1.153 | 0.364 | 9.481 | < 0.001 | 0.715 | 0.463-0.972 | 
| c-kit | -1.224 | 0.537 | 10.752 | < 0.001 | 0.643 | 0.368-0.835 | 
            Table 4 Diagnostic value of endothelin-1, interleukin-6, stem cell factor c-kit, and their combination for hypertension with depression
        
    | Indicator | Optimal cutoff value | AUC | 95%CI | P value | Sensitivity (%) | Specificity (%) | 
| ET-1 | 165.73 ng/L | 0.746 | 0.675-0.832 | < 0.05 | 72.56 | 75.38 | 
| IL-6 | 96.04 ng/L | 0.801 | 0.743-0.889 | < 0.05 | 75.43 | 67.62 | 
| SCF | 847.36 ng/L | 0.732 | 0.654-0.817 | < 0.05 | 70.85 | 74.19 | 
| c-kit | 11.53 μg/L | 0.779 | 0.707-0.876 | < 0.05 | 77.62 | 70.57 | 
| Combined | - | 0.884 | 0.813-0.957 | < 0.05 | 90.24 | 85.37 | 
- Citation: Wang WY, Wu Y, Zhang JQ, Li B. Expression differences and relationships of endothelin-1, interleukin-6 and c-kit in hypertensive patients with and without depression. World J Psychiatry 2025; 15(7): 106733
 - URL: https://www.wjgnet.com/2220-3206/full/v15/i7/106733.htm
 - DOI: https://dx.doi.org/10.5498/wjp.v15.i7.106733
 
